TR200400049T2 - Eimeria maxima gametositinden rekombinant 56 ve 82 kda antijenleri kodlayan nükleik asitler - Google Patents

Eimeria maxima gametositinden rekombinant 56 ve 82 kda antijenleri kodlayan nükleik asitler

Info

Publication number
TR200400049T2
TR200400049T2 TR2004/00049T TR200400049T TR200400049T2 TR 200400049 T2 TR200400049 T2 TR 200400049T2 TR 2004/00049 T TR2004/00049 T TR 2004/00049T TR 200400049 T TR200400049 T TR 200400049T TR 200400049 T2 TR200400049 T2 TR 200400049T2
Authority
TR
Turkey
Prior art keywords
kda
recombinant
eimeria maxima
provides
present
Prior art date
Application number
TR2004/00049T
Other languages
English (en)
Inventor
Sabina Belli I.
Nicolas Smith C.
Wallach Michael
Original Assignee
Biological Laboratories Teva Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biological Laboratories Teva Ltd. filed Critical Biological Laboratories Teva Ltd.
Publication of TR200400049T2 publication Critical patent/TR200400049T2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455Eimeria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş , meleküller ağırlıkları 56 ve 82 kDA olan ana Eimeria maxima gametosit antijenlerinden ikisinin rekombinant klonlanmasını ve sıralanmasını ve bu rekombinant antijenlerin plazmit pTrcHis kullanılarak bir E.coli tanım sistemi içerisinde tanımlanmasını sağlar. Söz konusu buluş, kokidioz'a karşı rekombinant 56 kDa veya 82 kDa'lık antijen ihtiva eden bir aşı da sağlar. Söz konusu buluş, N-terminal ucunda burada tarif edilen amino asit sekansına sahip Eimeria maxima gametositlerine ait iki 30 kDa'lık protein ve üç 14 kDa'lık protein de sağlar. Söz konusu buluş, kokidioz'a karşı rekombinant 56 kDa veya 82 kDa'lık antijen ve yukarıda adı geçen proteinlerden herhangi birini içeren bir aşı da sağlar
TR2004/00049T 2001-07-06 2002-07-03 Eimeria maxima gametositinden rekombinant 56 ve 82 kda antijenleri kodlayan nükleik asitler TR200400049T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30369901P 2001-07-06 2001-07-06

Publications (1)

Publication Number Publication Date
TR200400049T2 true TR200400049T2 (tr) 2009-01-21

Family

ID=23173289

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/00049T TR200400049T2 (tr) 2001-07-06 2002-07-03 Eimeria maxima gametositinden rekombinant 56 ve 82 kda antijenleri kodlayan nükleik asitler

Country Status (18)

Country Link
US (2) US7423137B2 (tr)
EP (1) EP1432722B1 (tr)
JP (2) JP2005501533A (tr)
CN (1) CN1606565B (tr)
AT (1) ATE454392T1 (tr)
AU (1) AU2002316558B2 (tr)
BR (1) BR0210853A (tr)
CA (1) CA2467006A1 (tr)
DE (1) DE60235021D1 (tr)
ES (1) ES2339227T3 (tr)
HU (1) HUP0600028A3 (tr)
IL (2) IL159716A0 (tr)
MX (1) MXPA04000127A (tr)
PL (1) PL366540A1 (tr)
RU (1) RU2004103469A (tr)
TR (1) TR200400049T2 (tr)
WO (1) WO2003004683A2 (tr)
ZA (1) ZA200400479B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ286915A (en) * 1995-07-03 1998-03-25 Akzo Nobel Nv Protein with one or more antigenic determinants of eimeria lactate dehydrogenase, its production and use
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
RU2004103468A (ru) 2001-07-06 2005-04-20 Абик Байолоджикал Лэборетериз Тева Лтд. (Il) Нуклеиновые кислоты, кодирующие рекомбинантный 250 к-да-антиген спорозоитов/мерозоитов eimeria maxima, и их применения
PL2066339T3 (pl) 2006-09-18 2015-02-27 Univ Arkansas Kompozycje i sposoby zwiększania odpowiedzi immunologicznych
CA3156538C (en) 2007-11-01 2023-12-12 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria
US20100150958A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. Methods and Compositions for Use of a Coccidiosis Vaccine
ES2968398T3 (es) 2013-02-14 2024-05-09 Univ Arkansas Composiciones y métodos para potenciar las respuestas inmunitarias a Eimeria o limitar la infección por Eimeria
CN106659787A (zh) * 2014-05-23 2017-05-10 辉宝动物保健公司 组合、组合物及向动物施用所述组合或组合物的方法
CN111471107B (zh) * 2020-04-27 2023-04-18 中国农业大学 抗鸡球虫多价重组蛋白卵黄抗体及其制备方法和应用
CN111840529B (zh) * 2020-07-30 2023-08-25 广东省农业科学院动物卫生研究所 一种柔嫩艾美耳球虫重组多肽疫苗vkvq的制备及其在抗鸡球虫病中的应用方法
CN113521264A (zh) * 2021-07-14 2021-10-22 中国农业科学院北京畜牧兽医研究所 一种鸽球虫病活疫苗及其制备方法和应用
CN114051971B (zh) * 2021-08-26 2023-08-29 山东农巧农业科技有限公司 一种高效率乳鸽生态养殖方法
CN114736308B (zh) * 2022-03-15 2022-12-27 四川宜美康科技有限公司 球虫抗原肽/il5的融合蛋白基因工程菌的制备及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135712A3 (en) 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp.
CA1340520C (en) 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
US4639372A (en) 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US5496550A (en) 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
IL83523A (en) * 1986-08-14 1994-10-21 Chilwalner Partnership Method of purification of eimeria gametocytes and coccidiosis vaccine containing them
ZA893740B (en) * 1988-06-03 1990-02-28 Hoffmann La Roche Recombinant coccidiosis vaccines
ATE144146T1 (de) 1988-07-05 1996-11-15 British Tech Group Usa Gentechnologisch hergestellter coccidiose- impfstoff
ZA200400479B (en) 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use

Also Published As

Publication number Publication date
PL366540A1 (en) 2005-02-07
HUP0600028A3 (en) 2010-01-28
US7968695B2 (en) 2011-06-28
EP1432722A2 (en) 2004-06-30
IL159716A (en) 2010-06-16
ATE454392T1 (de) 2010-01-15
BR0210853A (pt) 2005-08-30
WO2003004683A3 (en) 2004-04-29
EP1432722B1 (en) 2010-01-06
MXPA04000127A (es) 2005-07-01
HUP0600028A2 (en) 2006-04-28
CA2467006A1 (en) 2003-01-16
RU2004103469A (ru) 2005-04-10
WO2003004683A2 (en) 2003-01-16
ES2339227T3 (es) 2010-05-18
US20050033042A1 (en) 2005-02-10
CN1606565B (zh) 2011-06-29
EP1432722A4 (en) 2005-08-10
CN1606565A (zh) 2005-04-13
US7423137B2 (en) 2008-09-09
JP2009077713A (ja) 2009-04-16
ZA200400479B (en) 2006-05-31
IL159716A0 (en) 2004-06-20
DE60235021D1 (de) 2010-02-25
US20090196888A1 (en) 2009-08-06
AU2002316558B2 (en) 2009-01-08
JP2005501533A (ja) 2005-01-20

Similar Documents

Publication Publication Date Title
TR200400049T2 (tr) Eimeria maxima gametositinden rekombinant 56 ve 82 kda antijenleri kodlayan nükleik asitler
CA2190473A1 (en) Recombinant papilloma virus l1
AR003124A1 (es) Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal,
BR0015137A (pt) Peptìdeos antigênicos de neisseria
ATE292685T1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
WO1997048370A3 (en) Vaccines comprising synthetic genes
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
WO2001079274A8 (en) Tuberculosis antigens and methods of use thereof
DE60238330D1 (de) Immunologisch bedeutende herpes-simplex-virus-antigene und verfahren für ihre verwendung
CY1108724T1 (el) ΑΝΟΣΟΠΟΙΗΣΗ ΓΑΛΑΚΤΟΠΑΡΑΓΩΓΩΝ ΑΓΕΛΑΔΩΝ ΜΕ ΧΙΜΑΙΡΙΚΗ GapC ΠΡΩΤΕΪΝΗ ΕΝΑΝΤΙ ΜΟΛΥΝΣΗΣ ΣΤΡΕΠΤΟΚΟΚΚΟΥ
DE69840998D1 (de) Ricin-ähnliche toxine zur therapie von kreb, viraler oder parasitärer infektionen
PT914437E (pt) Identificacao e clonagem de um antigenio micobacteriano correspondente a uma hemaglutinina de ligacao a heparina
CY1106433T1 (el) Εμβολια κοκκιδιωσης
ATE543513T1 (de) Anti-coronavirus impfstoff
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
TR200003498T2 (tr) Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları
WO1998040497A3 (en) An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
EE05139B1 (et) Peptiid, seda kodeeriv geen, reagent ja reaktiivikomplekt riketsioosi tuvastamiseks ning peptiidi sisaldav vaktsiin
ATE454394T1 (de) Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen
TH77236A (th) การเข้ารหัสกรดนิวคลีอิคของรีคอมบิแนนท์ 56 และ 82 kDa แอนติเจนจากแกมีโตไซต์ของ Eimeria maxima และการใช้งานของมัน
TH23725A (th) วัคซีนป้องกันโรคบิดสำหรับสัตว์ปีก
NZ512308A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1624063A3 (en) Chimeric gene encoding the antigenic determinants of four proteins of L. infantum
TH77072B (th) กรดนิวคลีอิกที่ทำรหัสแอนติเจน ตัวเชื่อมโยง 230 kDa จากสปอโรโซไอต์/มีโรโซไอต์ ของ Eimeria maxima, และการนำไปใช้